Carolyn Bonner
Keine laufenden Positionen mehr
Vermögen: 44 675 $ am 31.03.2024
Profil
Carolyn Bonner currently works at Skinject, Inc., as Director from 2023 and Medicus Pharma Ltd., as President.
Ms. Bonner also formerly worked at Parkway Clinical Laboratories, Inc., as President & Chief Executive Officer, Building Beyond BRIC Investment Fund LP, as Director-Corporate Development, and Interactive Capital Partners Corp., as President.
Ms. Bonner received her undergraduate degree from West Chester University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
0,15% | 24.10.2023 | 25 000 ( 0,15% ) | 44 675 $ | 31.03.2024 |
Aktive Positionen von Carolyn Bonner
Unternehmen | Position | Beginn |
---|---|---|
Skinject, Inc.
Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Direktor/Vorstandsmitglied | 18.10.2023 |
Ehemalige bekannte Positionen von Carolyn Bonner
Unternehmen | Position | Ende |
---|---|---|
Parkway Clinical Laboratories, Inc.
Parkway Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Parkway Clinical Laboratories, Inc. operates a clinical reference laboratory that performs routine and esoteric diagnostic testing services. The firm provides addiction management, body fluid testing, integrative diagnostic, pain management, opioid prescription monitoring, and workforce screening services. It also supports anti-aging and wellness providers in the initial diagnosis and ongoing care of patients suffering from chronic diseases, nutritional deficiencies, and cardiovascular risks. The company is headquartered in Bensalem, PA. | Vorstandsvorsitzender | - |
Building Beyond BRIC Investment Fund LP | Corporate Officer/Principal | - |
Interactive Capital Partners Corp.
Interactive Capital Partners Corp. Financial ConglomeratesFinance Interactive Capital Partners Corp. operates as a capital pool company. It is formed for the purpose of identification, evaluation and acquisition of assets, properties or businesses or participation. The company was founded on April 30, 2008 and is headquartered in Burlington, Canada. | Präsident | - |
Ausbildung von Carolyn Bonner
West Chester University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Interactive Capital Partners Corp.
Interactive Capital Partners Corp. Financial ConglomeratesFinance Interactive Capital Partners Corp. operates as a capital pool company. It is formed for the purpose of identification, evaluation and acquisition of assets, properties or businesses or participation. The company was founded on April 30, 2008 and is headquartered in Burlington, Canada. | Finance |
Parkway Clinical Laboratories, Inc.
Parkway Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Parkway Clinical Laboratories, Inc. operates a clinical reference laboratory that performs routine and esoteric diagnostic testing services. The firm provides addiction management, body fluid testing, integrative diagnostic, pain management, opioid prescription monitoring, and workforce screening services. It also supports anti-aging and wellness providers in the initial diagnosis and ongoing care of patients suffering from chronic diseases, nutritional deficiencies, and cardiovascular risks. The company is headquartered in Bensalem, PA. | Health Services |
Building Beyond BRIC Investment Fund LP | |
Skinject, Inc.
Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Health Services |